{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:41:39Z","timestamp":1790275299588,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T00:00:00Z","timestamp":1745712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92709-y","type":"journal-article","created":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:35:34Z","timestamp":1745750134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Implementation of pooled testing to increase access to routine viral load monitoring for people living with HIV on antiretroviral therapy"],"prefix":"10.1038","volume":"15","author":[{"given":"Gladys E.","family":"Fosah Tayong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comfort","family":"Vuchas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngha Ndze","family":"Mbuh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubaida N.","family":"Suiteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Mbuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley Che","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Franck Zeh","family":"Meka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge C.","family":"Billong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Djubgang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ashuntantang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Kum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Fokam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses","family":"Samje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,27]]},"reference":[{"key":"92709_CR1","unstructured":"World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring; recommendations for a public health approach.  https:\/\/iris.who.int\/bitstream\/handle\/10665\/342899\/9789240031593-eng.pdf?sequence=1 (2021)."},{"key":"92709_CR2","unstructured":"UNAIDS. The urgency of now: AIDS at a crossroads. https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024 (2024)."},{"key":"92709_CR3","unstructured":"World Health Organization. The role of HIV viral suppression in improving individual health and reducing transmission: policy brief. https:\/\/www.who.int\/publications\/i\/item\/9789240055179 (2023) ISBN 978-92-4-005517-9."},{"key":"92709_CR4","unstructured":"World Health Organization (WHO). HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. https:\/\/www.who.int\/publications\/i\/item\/9789240022232 (2021)."},{"key":"92709_CR5","unstructured":"World Health Organization (WHO). HIV Molecular Diagnostics Toolkit to Improve Access to Viral Load Testing and Infant Diagnosis. (2019)."},{"key":"92709_CR6","unstructured":"UNAIDS, Global & Geneva AIDS Strategy 2021\u20132026 - End Inequalities. End AIDS. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/global-AIDS-strategy-2021-2026_en.pdf (2021)."},{"key":"92709_CR7","doi-asserted-by":"publisher","unstructured":"Clinton Health Access Initiative (CHAI). HIV Market Report 2023. https:\/\/www.clintonhealthaccess.org\/report\/2023-hiv-market-report-the-state-of-hiv-market-in-low-and-middle-income-countries\/, https:\/\/doi.org\/10.1021\/ie50276a029 (2023)","DOI":"10.1021\/ie50276a029"},{"key":"92709_CR8","unstructured":"The Global Fund to Fight AIDS Tuberculosis and Malaria. Price Reference Report. Price & Quality Reporting database https:\/\/www.theglobalfund.org\/en\/sourcing-management\/price-quality-reporting\/ (2024)."},{"key":"92709_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-13504-2","volume":"22","author":"MD Pham","year":"2022","unstructured":"Pham, M. D., Nguyen, H. V., Anderson, D., Crowe, S. & Luchters, S. Viral load monitoring for people living with HIV in the era of test and treat: progress made and challenges ahead \u2013 a systematic review. BMC Public. Health. 22, 1\u201323 (2022).","journal-title":"BMC Public. Health"},{"key":"92709_CR10","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1016\/S2214-109X(14)70342-0","volume":"3","author":"S Resch","year":"2015","unstructured":"Resch, S., Ryckman, T. & Hecht, R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. Lancet Glob Heal. 3, e52\u2013e61 (2015).","journal-title":"Lancet Glob Heal"},{"key":"92709_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/cid\/ciw001","volume":"62","author":"T Roberts","year":"2016","unstructured":"Roberts, T., Cohn, J., Bonner, K. & Hargreaves, S. Scale-up of routine viral load testing in resource-poor settings: current and future implementation challenges. Clin. Infect. Dis. 62, 1043\u20131048 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"92709_CR12","doi-asserted-by":"crossref","unstructured":"Vojnov, L. et al. The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and Meta-Analysis. PLoS Med. 19 (2022).","DOI":"10.1371\/journal.pmed.1004076"},{"key":"92709_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/QAD.0000000000002303","volume":"33","author":"JA Sacks","year":"2019","unstructured":"Sacks, J. A. et al. Performance of cepheid Xpert HIV-1 viral load plasma assay to accurately detect treatment failure. AIDS 33, 1881\u20131889 (2019).","journal-title":"AIDS"},{"key":"92709_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jcv.2011.09.015","volume":"52","author":"BR Cobb","year":"2011","unstructured":"Cobb, B. R., Vaks, J. E., Do, T. & Vilchez, R. A. Evolution in the sensitivity of quantitative HIV-1 viral load tests. J. Clin. Virol. 52, 77\u201382 (2011).","journal-title":"J. Clin. Virol."},{"key":"92709_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1128\/JCM.00578-12","volume":"50","author":"C Jennings","year":"2012","unstructured":"Jennings, C. et al. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J. Clin. Microbiol. 50, 2737\u20132747 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"92709_CR16","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1002\/jmv.25877","volume":"92","author":"N Lelie","year":"2020","unstructured":"Lelie, N. & van Drimmelen, H. Accuracy of quantitative HIV-1 RNA test methods at 1000 copies\/ml and the potential impact of differences in assay calibration on therapy monitoring of patients. J. Med. Virol. 92, 3246\u20133253 (2020).","journal-title":"J. Med. Virol."},{"key":"92709_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1214\/aoms\/1177731363","volume":"14","author":"R Dorfman","year":"1943","unstructured":"Dorfman, R. The detection of defective members of large populations. Ann. Math. Stat. 14, 436\u2013440 (1943).","journal-title":"Ann. Math. Stat."},{"key":"92709_CR18","unstructured":"Bilder, C. R. A Shiny App for Pooled Testing. https:\/\/bilder.shinyapps.io\/PooledTesting\/"},{"key":"92709_CR19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1128\/JCM.00787-07","volume":"46","author":"DJ Westreich","year":"2008","unstructured":"Westreich, D. J., Hudgens, M. G., Fiscus, S. A. & Pilcher, C. D. Optimizing screening for acute human immunodeficiency virus infection with pooled nucleic acid amplification tests. J. Clin. Microbiol. 46, 1785\u20131792 (2008).","journal-title":"J. Clin. Microbiol."},{"key":"92709_CR20","doi-asserted-by":"crossref","unstructured":"Schalkwyk, C., Van, Maritz, J., Zyl, G. U., Van, Preiser, W. & Welte, A. Pooled PCR testing of dried blood spots for infant HIV diagnosis is cost efficient and accurate. BMC Infect. Dis. 19, (2019).","DOI":"10.1186\/s12879-019-3767-z"},{"key":"92709_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-41904-w","volume":"13","author":"C Vuchas","year":"2023","unstructured":"Vuchas, C. et al. Implementation of large \u2013 scale pooled testing to increase rapid molecular diagnostic test coverage for tuberculosis: a retrospective evaluation. Sci. Rep. 13, 1\u201310 (2023).","journal-title":"Sci. Rep."},{"key":"92709_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3201\/eid2703.204090","volume":"27","author":"LE Cuevas","year":"2021","unstructured":"Cuevas, L. E. et al. Systematic review of pooling sputum as an efficient method for Xpert MTB\/RIF tuberculosis testing during COVID-19 pandemic. Emerg. Infect. Dis. 27, 719\u2013727 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"92709_CR23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/s41591-024-02873-3","volume":"30","author":"L Merav","year":"2024","unstructured":"Merav, L. et al. Implementation of pooled saliva tests for universal screening of cCMV infection. Nat. Med. 30, 1111\u20131117 (2024).","journal-title":"Nat. Med."},{"key":"92709_CR24","doi-asserted-by":"crossref","unstructured":"Waters, A. et al. Incidence of congenital cytomegalovirus infection in Ireland: implications for screening and diagnosis. 59, 156\u2013160 (2014).","DOI":"10.1016\/j.jcv.2013.12.007"},{"key":"92709_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijid.2022.03.009","volume":"118","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. The diagnostic accuracy of pooled testing from multiple individuals for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review. Int. J. Infect. Dis. 118, 183\u2013193 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"92709_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/cid\/ciq084","volume":"52","author":"GU Zyl","year":"2011","unstructured":"Zyl, G. U. et al. Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a Resource-Limited setting. Clin. Infect. Dis. 52, 264\u2013270 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"92709_CR27","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1097\/QAD.0b013e3283313ca9","volume":"23","author":"DM Smith","year":"2009","unstructured":"Smith, D. M. et al. The use of pooled viral load testing to identify antiretroviral treatment failure. AIDS 23, 2151\u20132158 (2009).","journal-title":"AIDS"},{"key":"92709_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/QAI.0b013e3181ba37a7","volume":"53","author":"SJ May","year":"2011","unstructured":"May, S. J., Gamst, A., Haubrich, R., Benson, C. & Smith, D. M. Pooled nucleic acid testing to identify antiretroviral treatment failure during HIV infection. J. Acquir. Immune Defic. Syndr. 53, 194\u2013201 (2011).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"92709_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/QAI.0b013e3182a61e63","volume":"64","author":"P Pannus","year":"2013","unstructured":"Pannus, P. et al. Pooled HIV-1 viral load testing using dried blood spots to reduce the cost of monitoring antiretroviral treatment in a resource-limited setting. J. Acquir. Immune Defic. Syndr. 64, 134\u2013137 (2013).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"92709_CR30","doi-asserted-by":"publisher","first-page":"a1035","DOI":"10.4102\/ajlm.v9i2.1035","volume":"9","author":"W Preiser","year":"2020","unstructured":"Preiser, W. & van Zyl, G. U. Pooled testing: A tool to increase efficiency of infant HIV diagnosis and virological monitoring. Afr. J. Lab. Med. 9, a1035 (2020).","journal-title":"Afr. J. Lab. Med."},{"key":"92709_CR31","doi-asserted-by":"publisher","first-page":"583377","DOI":"10.3389\/fpubh.2021.583377","volume":"9","author":"CM Verdun","year":"2021","unstructured":"Verdun, C. M., Fuchs, T., Harar, P., Elbr\u00e4chter, D. & Fischer, D. S. Group testing for SARS-CoV-2 allows for up to 10-Fold efficiency increase across realistic scenarios and testing strategies. Front. Public. Heal. 9, 583377 (2021).","journal-title":"Front. Public. Heal"},{"key":"92709_CR32","doi-asserted-by":"publisher","first-page":"115432","DOI":"10.1016\/j.diagmicrobio.2021.115432","volume":"101","author":"EA Daniel","year":"2020","unstructured":"Daniel, E. A. et al. Pooled testing strategies for SARS-CoV-2 diagnosis: A comprehensive review. Diagn. Microbiol. Infect. Dis. 101, 115432 (2020).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"92709_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.abf2823","volume":"13","author":"N Barak","year":"2021","unstructured":"Barak, N. et al. Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests. Sci. Transl Med. 13, 1\u20138 (2021).","journal-title":"Sci. Transl Med."},{"key":"92709_CR34","doi-asserted-by":"publisher","first-page":"e54503","DOI":"10.2196\/54503","volume":"10","author":"JJ Cabrera Alvargonzalez","year":"2024","unstructured":"Cabrera Alvargonzalez, J. J. et al. Assessment of the effective sensitivity of SARS-CoV-2 sample pooling based on a large-scale screening experience: retrospective analysis. JMIR Public. Heal Surveill. 10, e54503 (2024).","journal-title":"JMIR Public. Heal Surveill"},{"key":"92709_CR35","doi-asserted-by":"publisher","unstructured":"Bilder, C. R., Tebbs, J. M. & Mcmahan, C. S. Discussion on is group testing ready for prime-time in disease identification. Stat. Med. 3881\u20133886. https:\/\/doi.org\/10.1002\/sim.8988 (2021).","DOI":"10.1002\/sim.8988"},{"key":"92709_CR36","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/ajcp\/aqaa064","volume":"153","author":"B Abdalhamid","year":"2020","unstructured":"Abdalhamid, B. et al. Assessment of specimen pooling to conserve SARS CoV-2 testing resources. Am. J. Clin. Pathol. 153, 715\u2013718 (2020).","journal-title":"Am. J. Clin. Pathol."},{"key":"92709_CR37","unstructured":"U.S. Food and Drug Administration (FDA). Template for Developers of Molecular Diagnostic Tests. vol. 1, 1\u201360 https:\/\/www.fda.gov\/media\/135900\/download (2021)."},{"key":"92709_CR38","unstructured":"LabCorp. Labcorp\u2019s COVID-19 RT-PCR, Test, E. U. A. & Summary LabCorp 1\u201333 https:\/\/www.fda.gov\/media\/136151\/download (2022)."},{"key":"92709_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3343\/alm.2022.42.4.391","volume":"42","author":"KH Hong","year":"2022","unstructured":"Hong, K. H. et al. Update of guidelines for laboratory diagnosis of COVID-19 in Korea. Ann. Lab. Med. 42, 391\u2013397 (2022).","journal-title":"Ann. Lab. Med."},{"key":"92709_CR40","unstructured":"Institut National de la Statistique (INS). et ICF. Enqu\u00eate D\u00e9mographique et de Sant\u00e9 du Cameroun 2018. https:\/\/dhsprogram.com\/publications\/publication-FR360-DHS-Final-Reports.cfm (2020)."},{"key":"92709_CR41","unstructured":"National AIDS Control Committee. Annual Report of the HIV Response, Cameroon. http:\/\/cnls.cm (2021)."},{"key":"92709_CR42","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.3390\/biomedicines12092083","volume":"12","author":"J Fokam","year":"2024","unstructured":"Fokam, J. et al. Evaluation of viral suppression in paediatric populations: implications for the transition to Dolutegravir-Based regimens in Cameroon: the CIPHER-ADOLA study. Biomedicines 12, 2083 (2024).","journal-title":"Biomedicines"},{"key":"92709_CR43","doi-asserted-by":"crossref","unstructured":"Fokam, J. et al. Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon. Med. (Baltim). 102, (2023).","DOI":"10.1097\/MD.0000000000033737"},{"key":"92709_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0235958","volume":"15","author":"J Fokam","year":"2020","unstructured":"Fokam, J. et al. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon. PLoS One. 15, 1\u201314 (2020).","journal-title":"PLoS One"},{"key":"92709_CR45","doi-asserted-by":"crossref","unstructured":"Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. I, 307\u2013310 (1986).","DOI":"10.1016\/S0140-6736(86)90837-8"},{"key":"92709_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/096228029900800204","volume":"2802","author":"JM Bland","year":"1999","unstructured":"Bland, J. M. & Altman, D. G. Measuring agreement in method comparison studies. Stat. Methods Med. Res. 2802, 135\u2013160 (1999).","journal-title":"Stat. Methods Med. Res."},{"key":"92709_CR47","first-page":"709","volume":"21","author":"H Passing","year":"1983","unstructured":"Passing, H. & Bablok, W. A. New biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J. Clin. Chem. Clin. Biochem. 21, 709\u2013720 (1983).","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"92709_CR48","unstructured":"Abbott Abbott RealTime HIV-1 Assay Package Insert. https:\/\/www.molecular.abbott\/us\/en\/products\/infectious-disease\/realtime-hiv-1-viral-load"},{"key":"92709_CR49","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.r-project.org"},{"key":"92709_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bdq.2015.01.005","volume":"3","author":"D Svec","year":"2015","unstructured":"Svec, D., Tichopad, A., Novosadova, V., Pfaffl, M. W. & Kubista, M. How good is a PCR efficiency estimate: recommendations for precise and robust qPCR efficiency assessments. Biomol. Detect. Quantif. 3, 9\u201316 (2015).","journal-title":"Biomol. Detect. Quantif"},{"key":"92709_CR51","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin, S. A. et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611\u2013622 (2009).","journal-title":"Clin. Chem."},{"key":"92709_CR52","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1128\/AAC.00076-14","volume":"58","author":"P Ryscavage","year":"2014","unstructured":"Ryscavage, P., Kelly, S., Li, J. Z., Harrigan, R., Taiwo, B. & P. & Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients. Antimicrob. Agents Chemother. 58, 3585\u20133598 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"92709_CR53","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/S0140-6736(23)00877-2","volume":"402","author":"LN Broyles","year":"2023","unstructured":"Broyles, L. N., Luo, R., Boeras, D. & Vojnov, L. The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review. Lancet 402, 464\u2013471 (2023).","journal-title":"Lancet"},{"issue":"1","key":"92709_CR54","first-page":"409","volume":"28","author":"GC Chang","year":"2020","unstructured":"Chang, G. C. et al. Population-based HIV impact assessments and viral load results: implications for u\u2009=\u2009u. Top. Antivir Med. 28 (1), 409\u2013410 (2020).","journal-title":"Top. Antivir Med."},{"key":"92709_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s10729-021-09578-w","volume":"25","author":"LJ Basso","year":"2022","unstructured":"Basso, L. J., Salinas, V., Saur\u00e9, D., Thraves, C. & Yankovic, N. The effect of correlation and false negatives in pool testing strategies for COVID-19. Health Care Manag Sci. 25, 146\u2013165 (2022).","journal-title":"Health Care Manag Sci."},{"key":"92709_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1214\/22-STS857","volume":"37","author":"S Comess","year":"2022","unstructured":"Comess, S., Wang, H., Holmes, S. & Donnat, C. Statistical modeling for practical pooled testing during the COVID-19 pandemic. Stat. Sci. 37, 229\u2013250 (2022).","journal-title":"Stat. Sci."},{"key":"92709_CR57","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s10729-023-09650-7","volume":"26","author":"GQ Saraiva","year":"2023","unstructured":"Saraiva, G. Q. Pool testing with Dilution effects and heterogeneous priors. Health Care Manag Sci. 26, 651\u2013672 (2023).","journal-title":"Health Care Manag Sci."},{"key":"92709_CR58","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1287\/mnsc.2018.3138","volume":"65","author":"H Aprahamian","year":"2019","unstructured":"Aprahamian, H., Bish, D. R. & Bish, K. Optimal Risk-Based group testing. Manage. Sci. 65, 4365\u20134384 (2019).","journal-title":"Manage. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92709-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T10:35:40Z","timestamp":1745750140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92709"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92709-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,27]]},"assertion":[{"value":"17 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14713"}}